SYNTAX and CABG after two years

A new study, published in the Januari, 2011 issue of the Journal of Thoracic and Cardiovascular Surgery, reviewed 2-year follow-up outcome data of  1468 CABG patients from the SYNTAX trial.

Coronary artery bypass grafting (CABG), rather than percutaneous coronary intervention (PCI) continues to be the recommended primary revascularization strategy for patients with stable angina who have coronary triple vessel disease (3-VD) or left main (LM) disease.